Bridgeway Capital Management’s Kura Oncology KURA Stock Holding History

Bridgeway Capital Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-18,000	Closed	-$338K	–	1436
2018 Q1	$338K	Sell	18,000 -49,200	-73%	-$958K	﹤0.01%	1177
2017 Q4	$1.03M	Sell	67,200 -25,000	-27%	-$368K	0.01%	837
2017 Q3	$1.38M	Sell	92,200 -250	-0.3%	-$2.35K	0.02%	723
2017 Q2	$860K	Buy	92,450 +250	+0.3%	+$2.28K	0.01%	884
2017 Q1	$811K	Buy	92,200 +29,200	+46%	+$214K	0.01%	891
2016 Q4	$372K	Hold	63,000	–	–	﹤0.01%	1177
2016 Q3	$394K	Hold	63,000	–	–	0.01%	1171
2016 Q2	$171K	Hold	63,000	–	–	﹤0.01%	1335
2016 Q1	$255K	Buy	+63,000	New	+$299K	﹤0.01%	1251

Other funds holding KURA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridgeway Capital Management's KURA Position: Q2 2018 in Review

Bridgeway Capital Management sold out of Kura Oncology (KURA) in Q2 2018, closing a stake of 18,000 shares — an estimated $338K sold.

Bridgeway Capital Management first reported a position in KURA in Q1 2016 and held it in 9 quarters. The position peaked at $1.38M in Q3 2017. 107 funds tracked by Wall St. Rank hold KURA as of Q2 2018.

Bridgeway Capital Management reported no remaining Kura Oncology position as of Q2 2018 after selling out during the quarter.
Bridgeway Capital Management sold 18,000 Kura Oncology shares in Q2 2018, an estimated $338K.
Bridgeway Capital Management first reported a position in Kura Oncology in Q1 2016 and held it in 9 quarters.
Bridgeway Capital Management's Kura Oncology position peaked at $1.38M in Q3 2017.
107 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2018.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.